General Electric Healthcare is unveiling its vision for its future in healthcare, targeting 2015 as the bulls-eye for the realization of its vision of personalized medicine.

GE Healthcare’s go-to-market strategy is woven around the phrase “Predict, Diagnose, Inform, and Treat,” and, this week in Chicago, it will provide perhaps the most in-depth explanation on how it will integrate the tools it picked up by acquiring Amersham in April with its legacy medical systems business.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

US Attorney General Jeff Sessions is considering using DNA tests to determine relatedness between adult and child migrants, the Daily Caller reports.

Bloomberg reports that Brainstorm Cell Therapeutics plans to offer a treatment it is developing under the "right to try" law for hundreds of thousands of dollars.

In Nature this week: expansion of disease-resistance genes among long-lived oak trees, and more.

In a proof-of-concept study, researchers report being able to determine age from dried bloodstains, Discover's D-brief blog reports.